Company / Inventory
Amneal Pharmaceuticals, Inc. Inventory History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$606.3M
FY2025
5-year range
$489.4M / $612.5M
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
#22 of 105
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s inventory of $606M is higher than 79% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 9 years, ranging from $284M in FY2017 to $612M in FY2024.
Based on SEC 10-K filings.
$606M in FY2025 with a 5-year CAGR of +4.3%. Top quartile in the Health Care sector.
Improved from $581M to $606M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 105This company $606.3M Sector average $885.3M
▼
-31.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.3%, indicating consistent growth.
- In FY2025, inventory decreased 1.0% year-over-year.
- Ranks #22 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $606.3M | -1.0% |
| FY2024 | $612.5M | +5.3% |
| FY2023 | $581.4M | +9.5% |
| FY2022 | $530.7M | +8.4% |
| FY2021 | $489.4M | -0.3% |
| FY2020 | $490.6M | +28.8% |
| FY2019 | $381.1M | -16.7% |
| FY2018 | $457.2M | +61.0% |
| FY2017 | $284.0M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026